Clinical Trials Directory

Trials / Unknown

UnknownNCT03245632

Epidemiological Characteristics and Treatment Protocol for Carbapenem-Resistant Klebsiella Pneumoniae in China

Status
Unknown
Phase
Study type
Observational
Enrollment
800 (estimated)
Sponsor
Sir Run Run Shaw Hospital · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Klebsiella pneumoniae is one of the most common pathogens causing nosocomial infection. Recently, the emergency of Carbapenem-Resistant Klebsiella pneumoniae (CRKP) had cause the clinical therapy be very difficult. However, there is not much empirical data as to the prevalence, risk factors, characteristics, and the rationality of the current therapy for the CRKP infection. Thus, the study was aimed to investigate the epidemiology and risk factors, characteristics, and the rationality of the current therapy for the CRKP infection.

Detailed description

All the patients with culture positive of Klebsiella pneumoniae were screened and reported to the the clinical doctors and confirmed by them. And the clinical characteristics of the patiens, such as baseline data, outcomes etc, were recorded. Finially, to find the prevalence, risk factors, characteristics, and the rationality of the current therapy for the CRKP infection

Conditions

Interventions

TypeNameDescription
OTHERCarbapenem-Resistant Klebsiella pneumoniaeno intervention, this is an obervational study.

Timeline

Start date
2017-08-01
Primary completion
2019-07-01
Completion
2019-12-01
First posted
2017-08-10
Last updated
2017-08-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03245632. Inclusion in this directory is not an endorsement.